Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-211517
Filing Date
2013-05-10
Accepted
2013-05-09 17:35:55
Documents
10
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d511721d10q.htm 10-Q 566078
2 EX-31.1 d511721dex311.htm EX-31.1 9961
3 EX-31.2 d511721dex312.htm EX-31.2 10147
4 EX-32 d511721dex32.htm EX-32 4013
  Complete submission text file 0001193125-13-211517.txt   2765785

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT pvct-20130331.xml EX-101.INS 255832
6 XBRL TAXONOMY EXTENSION SCHEMA pvct-20130331.xsd EX-101.SCH 36637
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pvct-20130331_cal.xml EX-101.CAL 43448
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pvct-20130331_def.xml EX-101.DEF 110219
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE pvct-20130331_lab.xml EX-101.LAB 244120
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pvct-20130331_pre.xml EX-101.PRE 172504
Mailing Address 7327 OAK RIDGE HWY SUITE B KNOXVILLE TN 37931
Business Address 7327 OAK RIDGE HWY SUITE B KNOXVILLE TN 37931 865-769-4011
PROVECTUS PHARMACEUTICALS INC (Filer) CIK: 0000315545 (see all company filings)

EIN.: 900031917 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-09410 | Film No.: 13830279
SIC: 2834 Pharmaceutical Preparations